...
首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.
【24h】

Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.

机译:新诊断的淋巴瘤:与18F-FDG PET / CT相比,全身T1加权,STIR和扩散加权MRI的初步结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The purpose of this study was to compare whole-body MRI including diffusion-weighted imaging (DWI) with (18)F-FDG PET/CT in the staging of newly diagnosed lymphoma. SUBJECTS AND METHODS: Twenty-two consecutively registered patients with newly diagnosed lymphoma prospectively underwent whole-body MRI (22 with T1-weighted, STIR, and DWI sequences and 21 with T1-weighted and STIR sequences but not DWI) and FDG PET/CT. Whole-body MRI-DWI was independently evaluated by two blinded observers. Interobserver agreement was assessed, and whole-body MRI-DWI was compared with FDG PET/CT. RESULTS: The kappa values for interobserver agreement on whole-body MRI-DWI for all nodal regions together and for all extranodal regions together were 0.676 and 0.452. The kappa values for agreement between whole-body MRI-DWI and FDG PET/CT for all nodal regions together and for all extranodal regions together were 0.597 and 0.507. Ann Arbor stage according to whole-body MRI-DWI findings was concordant with that of FDG PET/CT findings in 77% (17/22) of patients. Understaging and overstaging relative to the findings with FDG PET/CT occurred in 0% (0/22) and 23% (5/22) of cases. In the care of 9% (2/22) of patients, overstaging with whole-body MRI-DWI relative to staging with FDG PET/CT would have had therapeutic consequences. CONCLUSION: Our early results indicate that overall interobserver agreement on whole-body MRI-DWI findings is moderate to good. Overall agreement between whole-body MRI-DWI and FDG PET/CT is moderate. In the care of patients with newly diagnosed lymphoma, staging with whole-body MRI-DWI does not result in underestimation of stage relative to the results with FDG PET/CT. In a minority of patients, reliance on whole-body MRI-DWI leads to clinically important overstaging relative to the results with FDG PET/CT. FDG PET/CT remains the reference standard for lymphoma staging until larger-scale studies show that use of whole-body MRI-DWI results in correct staging in this minority of cases.
机译:目的:本研究的目的是比较包括弥散加权成像(DWI)在内的全身MRI与(18)F-FDG PET / CT在新诊断的淋巴瘤分期中的作用。研究对象和方法:22名连续登记的新诊断淋巴瘤患者均接受了全身MRI(22例具有T1加权,STIR和DWI序列,而21例具有T1加权和STIR序列但不包括DWI)和FDG PET / CT 。两名失明的观察者对全身MRI-DWI进行了独立评估。评估观察者之间的一致性,并将全身MRI-DWI与FDG PET / CT进行比较。结果:全身MRI-DWI的观察者间一致性的kappa值分别为所有结点区域和所有结外区域的kappa值为0.676和0.452。全身MRI-DWI和FDG PET / CT之间对于所有节点区域以及对于所有结外区域而言,一致性的kappa值为0.597和0.507。根据全身MRI-DWI结果,Ann Arbor分期与77%(17/22)患者的FDG PET / CT结果一致。相对于FDG PET / CT的发现,分期不足和过度进行的案例分别为0%(0/22)和23%(5/22)。在9%(2/22)的患者中,全身MRI-DWI的分期相对于FDG PET / CT的分期会产生治疗效果。结论:我们的早期结果表明,对全身MRI-DWI发现的总体观察者相互同意程度为中度至良好。全身MRI-DWI和FDG PET / CT之间的总体一致性中等。在新诊断的淋巴瘤患者的护理中,相对于FDG PET / CT的结果,全身MRI-DWI的分期不会导致分期低估。在少数患者中,相对于FDG PET / CT的结果,依赖全身MRI-DWI导致临床上重要的过度分期。 FDG PET / CT仍然是淋巴瘤分期的参考标准,直到更大规模的研究表明,在少数病例中使用全身MRI-DWI可以正确分期。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号